We have purified, sequenced, and prepared a synthetic clone of a small (60-nucleotide) RNA molecule from the yeast Saccharomyces cerevisiae that had previously been isolated on the basis of its ability to selectively block the translation of poliovirus mRNA. RNA derived from the clone by transcription with T7 RNA polymerase appears to block translation initiation by internal ribosome entry (cap independent) but does not significantly affect cap-dependent translation. Deletion analysis of the poliovirus 5'-untranslated region (5'-UTR) has shown that yeast inhibitor RNA (I-RNA) requires internal ribosome entry site sequences to inhibit the translation of poliovirus RNA in vitro. Using a bicistronic RNA construct, we show that I-RNA preferentially inhibits translation by internal ribosome entry. Gel retardation and UV cross-linking studies demonstrate that
Poliovirus, the prototype member of the Picomaviridae family, is a single-stranded, plus-sense RNA virus which multiplies in the cytoplasm of infected cells. The genome RNA is approximately 7,500 nucleotides long and codes for a 250-kDa polyprotein (25, 44) . The polyprotein is cleaved by three virus-encoded proteases, resulting in the synthesis of mature virus structural and nonstructural proteins. The unusually long 5'-untranslated region (5'-UTR) of poliovirus RNA (750 nucleotides) is highly structured (1, 48) and contains six to eight upstream AUG codons, none of which appear to be used in translation (36) . Translation of the majority of cellular mRNAs proceeds by the binding of ribosomes to the 5' cap structure followed by the scanning of mRNA until the appropriate AUG is encountered by the ribosome (27) . In sharp contrast, the translation of naturally uncapped poliovirus RNA has been shown to be mediated by a mechanism involving the internal entry of ribosomes near the initiator AUG (39) . Recent studies have demonstrated that the internal entry of ribosomes requires an element located between nucleotides 320 and 631 within the 5'-UTR of poliovirus RNA (39) . This sequence element has been termed the ribosome landing pad or, more generally, the internal ribosome entry site (IRES). Although a number of cellular polypeptides have been implicated in IRES-dependent translation, the precise mechanism(s) of internal initiation of translation remains poorly understood. In addition to poliovirus, many other picornaviruses have been shown to utilize this novel mechanism for the initiation of translation (3-6, 21, 22, 28, 29) . The RNA genomes of another picornavirus, hepatitis A, and a flavivirus, hepatitis C, have been shown to utilize internal ribosome entry for translation initiation (16, 26) . Two cellular mRNAs, which encode immunoglobulin heavy-chain binding protein (Bip) and the Antennapedia protein of Drosophila melanogaster, have also been shown to use internal initiation of translation (30, 34) . All picornavirus mRNAs that utilize IRES-dependent translation contain a polypyrimidine tract located at the 3' border of the IRES sequences within the 5'-UTR. Recent evidence suggests that proper spacing between the polypyrimidine tract and the cryptic AUG at nucleotide 586 of the poliovirus 5'-UTR is important for viral translation (21, 23, 43) .
Accurate translation of poliovirus mRNA in rabbit reticulocyte lysate requires HeLa cell proteins, suggesting the involvement of cellular proteins in internal initiation of translation (8, 14) . A 50-kDa protein has been shown to interact with the RNA stem-loop structure located between nucleotides 186 and 221 in poliovirus type 1 RNA (33) . The physiological significance of this binding is still unclear. Another protein, called p52, present in abundance in HeLa cells compared with rabbit reticulocytes has been found to specifically bind to the stemloop structure between nucleotides 559 and 624 of type 2 poliovirus (31) . The p52 protein appears to be identical to human La autoantigen (32) . This nuclear protein, recognized by antibodies from patients with the autoimmune disorder lupus erythematosus, leaches out of the nucleus into the cytoplasm in poliovirus-infected HeLa cells. Cell extracts immunodepleted with La antibodies fail to promote cap-independent translation, and the addition of exogenous purified La protein corrects aberrant translation of poliovirus RNA in reticulocyte lysate which contains little or no p52 (32) . UV cross-linking studies have demonstrated that another cellular protein, p57, interacts with the IRES elements of encephalomyocarditis virus (EMCV), foot-and-mouth disease virus, rhinovirus, poliovirus, and hepatitis A virus (5, 7, 9, 23, 24, 29, 40, 42) . It has recently been demonstrated that p57 binding to the IRES of EMCV is identical to that of polypyrimidine tractbinding protein (PTB), which presumably plays a role in nuclear splicing (20) . Anti-PTB antibody inhibits the translation of EMCV and poliovirus RNAs, and thus PTB may be be directly involved in IRES-directed translation. In addition, two other cellular proteins with molecular masses of 38 and 48 kDa have previously been shown to specifically interact with RNA structures spanning nucleotides 286 and 456 of poliovirus. These two proteins are reported to be present in higher quantities in HeLa cells than in reticulocyte lysate and appear to be involved specifically in poliovirus translation (15) . Another 54-kDa protein cross-links to a region between nucleotides 457 and 626 and is required for the translation of all mRNAs (15) . A very recent report suggests a role for a 97-kDa protein in the IRES-dependent translation of human rhinovirus RNA (5) . RNA-protein complex formation has also been demonstrated with the regions encompassing nucleotides 98 to 182 and 510 to 629 of poliovirus RNA (12) . Taken together, these results suggest that picornavirus translation involves direct interaction between cellular factors and RNA sequences and secondary structures that leads to internal initiation. trans-acting proteins could direct ribosomes to enter the mRNA or could alter the RNA structure to facilitate ribosome binding.
In a previous study, we showed that yeast cells are incapable of translating poliovirus RNA both in vivo and in vitro and that this is a consequence of the 5'-UTR of virus RNA (10) . It (10) . The inhibitor bound strongly to the column and was eluted by washing the column with 1 M potassium acetate. Previous results from our laboratory showed that the activity of the inhibitor was not sensitive to proteinase or DNase treatments or to phenol extraction (10) . Thus, further purification of the DEAE-Sephacel-purified inhibitor involved DNase and proteinase K digestion followed by phenol-chloroform extraction. Finally, RNA obtained by alcohol precipitation of the aqueous phase was labeled with [-y-32P]ATP at the 5' end and RNA bands were resolved by 20% polyacrylamide-8 M urea gel electrophoresis. Each RNA band was eluted from gel slices and was assayed for its ability to inhibit IRES-mediated translation from a poliovirus 5'-UTR-chloramphenicol acetyltransferase (CAT) construct but not from a CAT construct known to initiate translation in a cap-dependent manner (38) . A single band which migrated as a 60-nucleotide RNA was associated with inhibitory activity. This RNA was sequenced with a commercially available sequencing kit. Figure 1A shows the sequence of the 60-nucleotide RNA. On the basis of the RNA sequence, sense-and antisense-strand-specific deoxyoligonucleotides were synthesized, annealed, and then cloned into the pGEM 3Z expression vector between the HindIII and EcoRI sites in the polylinker region. The recombinant plasmid was named pSDIR (Fig. 1B) . Transcription by T7 RNA polymerase from the linearized plasmid resulted in the synthesis of I-RNA. When analyzed by gel electrophoresis, a single RNA band of approximately 71 nucleotides was detected (Fig. 1C ). This consisted of the 60-nucleotide yeast I-RNA as well as 10 extra nucleotides with the EcoRI site from the 5' polylinker region and 1 nucleotide at the 3' end from the HindlIl site.
To determine whether RNA synthesized from the synthetic clone was active, its effect on translation from a CAT construct containing poliovirus 5'-UTR at the 5' end of the CAT gene (P2CAT) was determined. Both partially purified inhibitor from yeast and purified inhibitor transcribed from pSDIR inhibited translation from the P2CAT RNA in vitro in a HeLa cell extract (Fig. 1D, lanes 4 , 5, and 6). However, translation from CAT RNA (cap-dependent translation) was not significantly inhibited by the presence of these inhibitors (Fig. 1D , lanes 1, 2, and 3). Quantitation of CAT translation by densitometry showed no significant inhibition from the pG3CAT construct (Fig. 1D , lanes 2 and 3), while P2CAT translation was inhibited 40 and 60% (lanes 5 and 6), respectively. Thus, I-RNA synthesized from the synthetic clone was active in specifically inhibiting poliovirus IRES-dependent translation as previously found with partially purified inhibitor from yeast cells (10) . Figure 2D shows the deleted 5'-UTR-CAT constructs used for this purpose. The inhibitor efficiently inhibited translation from the P2CAT construct but not from the pG3CAT (or pCAT) construct (Fig.   1D ). Almost complete inhibition was observed when the A5'-33/CAT construct was translated in the presence of I-RNA (data not shown). Deletion of the first 320 nucleotides from the 5' end of the UTR did not have a significant effect on the ability of the inhibitor to inhibit translation from the A5'-320/ CAT construct ( Fig. 2A, lanes 1 and 2) . Significant inhibition of translation was observed in the presence of the inhibitor ( Fig. 2A, lanes 1 and 2) . Some of the inhibition observed could be reversed when template RNA was capped prior to translation ( Fig. 2A, lanes 3 and 4) . A similar result was obtained with the A3'-631/CAT construct; almost 75% inhibition of translation from this construct was observed in the presence of the inhibitor and the addition of capped RNA reversed the inhibition of translation to only 25% compared with that of the control (Fig. 2B, lanes 5 to 8) . In contrast, translation from the A5'-632/CAT construct was almost unaffected by the presence of the inhibitor (Fig. 2B, lanes 1 and 2) . Thus, almost the entire IRES region of virus RNA (nucleotides 320 to 631) was required for the inhibitor to efficiently inhibit poliovirus IRESdependent translation. A very interesting observation was that translation from the construct A5'-320/A3'-461/CAT, containing only nucleotides 320 to 461 of the UTR, was significantly inhibited by I-RNA (Fig. 2C, lanes 1 and 2) . This inhibition can be overcome to a significant extent by capping RNA prior to translation (Fig. 2C, lanes 3 and 4) . The stimulation of translation by capping deleted RNAs appears to be due to cap-dependent translation as cap analogs inhibit stimulated translation (data not shown). Although almost complete inhibition of IRES-dependent translation by the inhibitor required almost all of the UTR, significant inhibition was observed with a construct containing only nucleotides 320 to 461 of the virus UTR. Because capping RNAs prior to translation prevented . Protein-RNA complexes were analyzed on a nondenaturing gel. In lane 1, S10 extract was not added, i.e., free probe (FP). C, complex C.
the inhibition of translation to a significant extent, cap-dependent translation was probably not affected by the inhibitor, a result consistent with our previous observations (10).
I-RNA forms a gel-retarded complex that is inhibited by UTR. Theoretically, I-RNA could inhibit IRES-dependent translation by two possible mechanisms. It could bind to some sequences in the UTR as antisense RNA or it could bind protein factors needed for the internal entry of ribosomes, thus inhibiting IRES-dependent translation. The possibility that yeast I-RNA acts by binding protein factors required for IRES-dependent translation was plausible for the following reasons. First, purified RNA was not complementary to 5'-UTR sequences nor did it hybridize with virus 5'-UTR (data not shown). Secondly, inhibition of the translation of poliovirus RNA could be overcome by the addition of increasing concentrations of HeLa extract but not of poliovirus RNA or 5'-UTR sequence (10) . Therefore, 32P-body-labeled I-RNA probe was prepared and mixed with HeLa S10 extracts, and the resulting RNA-protein complexes were analyzed by nondenaturing polyacrylamide gel electrophoresis. As shown in Fig. 3 , lane 2, a single complex (denoted C) was clearly evident. The addition of increasing concentrations of unlabeled I-RNA inhibited the formation of the labeled complex (Fig. 3, lanes 3 and 4) . A similar result was obtained when unlabeled poliovirus 5'-UTR was used for competition (Fig. 3, lanes 5 and 6) . A nonspecific RNA, however, was not able to compete with labeled I-RNA (Fig. 3, lane 7) . Thus, I-RNA was able to form a gel-retarded complex with HeLa S10 proteins(s) that can be specifically competed with by virus 5'-UTR sequences. It should be noted that a significant amount of complex C remained in the presence of cold homologous I-RNA competitor (Fig. 3, lanes  3 and 4) . This result is consistent with the UV cross-linking studies discussed below, showing that many of the cross-linked bands could not be specifically inhibited by cold I-RNA competitor. The precise reason for this observation is unclear at present.
I-RNA binds proteins that interact with poliovirus 5'-UTR. To determine if specific polypeptides that interact with virus 5'-UTR also interact with yeast I-RNA, a series of UV cross-linking experiments were performed. In these experiments, body-labeled I-RNA was first incubated with HeLa S10 extract and then cross-linked by using UV light. After ribonuclease treatment, protein-nucleotide complexes were analyzed by SDS-polyacrylamide gel electrophoresis. When 32P-labeled I-RNA was used to cross-link proteins in HeLa extract, a number of polypeptides with approximate molecular masses of 100, 70, 52, and 37 kDa were detected ( Fig. 4A and B, lanes 2) . The addition of unlabeled I-RNA successfully competed with the 52-kDa band (Fig. 4A, lane 3) . It is unclear at present why significant amounts of the 100-, 70-, and 37-kDa bands remain in the presence of unlabeled I-RNA (Fig. 4A, lane 3) . When unlabeled poliovirus 5'-UTR was used as a competitor, the 52-kDa band as well as the 100-, 70-, and 37-kDa bands was completely inhibited (Fig. 4A, lane 4) . In contrast, the addition of unlabeled nonspecific RNA was unable to inhibit any of the polypeptides cross-linked to I-RNA (Fig. 4A, lane 5) . Because a 52-kDa protein has previously been shown to interact with a specific region of virus 5'-UTR (nucleotides 559 to 624), we determined whether an RNA containing this sequence [called UTR(559-624)] was able to inhibit the 52-kDa band crosslinked to labeled I-RNA. As shown in Fig. 4B , lane 4, unlabeled UTR(559-624) completely inhibited the formation of the I-RNA-52-kDa complex. Unlike 5'-UTR, UTR(559-624) only inhibited the 52-kDa band (compare lanes 4 in Fig.  4A and B) . These results suggest that yeast I-RNA binds a 52-kDa protein similar to that bound by poliovirus 5'-UTR nucleotides 559 to 624.
Yeast I-RNA competes with SL-G for protein binding. Poliovirus 5'-UTR contains a number of thermodynamically stable stem-loop structures that are believed to play important roles in virus RNA replication and translation (Fig. 5) . Nucleotides 186 to 221, which constitute SL-D, have been shown to bind a 50-kDa protein (p50) (33) . SL-G, representing poliovirus 5'-UTR sequences from nucleotides 559 to 624, binds to a 52-kDa protein (p52) which has recently been identified as the human La protein (32) . The results presented immediately above suggested that I-RNA interacts with p52, which normally binds to SL-G within the virus 5'-UTR. To confirm that similar proteins may be interacting with I-RNA and SL-G, the following competition experiments were performed. 32P-labeled 5'-UTR was incubated with HeLa S10 extract either alone or in the presence of various unlabeled competing RNAs (e.g., 5 '-UTR, SL-G, I-RNA, SL-B, SL-C, and nonspecific RNA). The resulting complexes were then analyzed by UV cross-linking studies. RNA sequences representing SL-B and SL-C were used as negative controls in these experiments as these sequences are not likely to interact with p52. When poliovirus 5'-UTR was used as the labeled probe, almost complete inhibition of the formation of the 52-kDa proteinnucleotidyl complex was observed with unlabeled UTR, I-RNA, and SL-G (Fig. 6A, lanes 3 to 6) . Unlabeled SL-B, SL-C, and nonspecific RNA were relatively ineffective in inhibiting the binding of 5'-UTR and p52 (Fig. 6A, lanes 7 to 9) . Only unlabeled UTR RNA inhibited the formation of all labeled bands, whereas I-RNA and SL-G specifically inhibited formation of the p52 band.
When SL-G was used as the labeled probe, a doublet migrating to 52 and 54 kDa was detected (Fig. 6B, lane 2) . Homologous competition with unlabeled SL-G completely inhibited the formation of these complexes (Fig. 6B, lane 3) . Almost 80% inhibition of the formation of these UV crosslinked complexes was observed in the presence of unlabeled I-RNA (Fig. 6B, lane 4) . However, no inhibition was observed when nonspecific, SL-B, or SL-C RNA was used as a competitor (Fig. 6B, lanes 5 to 7) . Taken together, these results suggest that similar proteins having approximate molecular masses of 52 kDa interact with I-RNA and SL-G.
The results presented above suggested that the inhibition of poliovirus IRES-dependent translation by I-RNA may be mediated at least in part by its interaction with the 52-kDa protein. To the A5'-320/A3'-461/CAT construct (Fig. 2) , which does not contain the p52-binding site, an RNA representing poliovirus sequence nucleotides 320 to 461 was used as the probe in UV cross-linking experiments. As shown in Fig. 7A , lane 6, incubation of the labeled probe with HeLa S10 extract resulted in the formation of a number of protein-nucleotidyl complexes. Among these bands was a doublet with approximate molecular masses of 54 and 52 kDa (indicated in the figure by arrowheads). The lower band of the doublet comigrated with protein-nucleotidyl complexes formed with labeled IRNA (Fig.  7A , lane 2) and 5'-UTR (lane 4). To further determine the nature of the lower band of this doublet, competition experiments were performed with unlabeled UTR, I-RNA, and SL-G (the p52-binding site). The addition of unlabeled UTR inhibited the formation of many of the bands except the uppermost and lowermost bands (Fig. 7A, lane 7) . In contrast, when unlabeled SL-G (the p52-binding site) was used as the competitor, only the formation of the lower band of the doublet was inhibited (Fig. 7A, lane 8) . A similar result was obtained when unlabled I-RNA was used as the competitor (Fig. 7A,  lane 9) . However, the addition of unlabeled, nonspecific RNA did not result in the disappearance of any complex (Fig. 7A,  lane 10 ). Homologous competition with unlabeled UTR(320-461) produced results similar to those with the whole UTR (Fig. 7A, lane 7 , and data not shown). Because the proteinnucleotidyl complexes (54 and 52 kDa) in the doublet were poorly resolved in Fig. 7A , a similar experiment in which the bands were better resolved by running the gel for a longer time was performed (Fig. 7B) . Some of the protein-nucleotidyl complexes in Fig. 7B were not present in high quantities in this experiment because a lower concentration of S10 was used here than was used in Fig. 7A . Additionally, the specific activity of the labeled probe in this experiment was much lower than that used in the previous experiment. These results suggest that a polypeptide that interacts with SL-G is also capable of interacting with nucleotides 320 to 461. Additionally, I-RNA is able to compete with UTR(320-461) for binding to this protein.
Yeast I-RNA inhibits IRES-mediated translation in vitro.
We previously showed that partially purified yeast I-RNA specifically inhibited the translation of monocistronic RNAs containing poliovirus 5'-UTR. However, cap-dependent translation of either CAT RNA or yeast mRNA was not affected by this inhibitor (10) . To examine if this cloned and purified RNA preferentially inhibits internal initiation of translation, its effect on translation from a bicistronic messenger was determined. For HeLa cell extracts, translation from the capped bicistronic message produced both CAT and luciferase proteins (Fig. 8A,  lane 1) . In the presence of purified yeast inhibitor, significant inhibition of luciferase synthesis was observed, whereas the synthesis of CAT was almost completely unaffected. Quantitation of the labeled CAT and luciferase bands showed that while luciferase synthesis was inhibited by over 70% compared with the control, no inhibition of CAT synthesis was observed in the presence of the inhibitor. When bicistronic RNA was translated in virus-infected cell extract, no CAT synthesis was detected as cap-dependent translation is inhibited in virusinfected cells (data not shown). The addition of purified inhibitor completely inhibited luciferase synthesis in infected extract (data not shown). These results suggest that yeast I-RNA preferentially inhibits the internal initiation of translation programmed by poliovirus 5'-UTR.
Recent results have shown that a few cellular mRNAs can initiate translation internally (30, 34) . The immunoglobulin heavy-chain Bip protein is among the proteins that can be synthesized by internal initiation. To determine whether Bip synthesis can be specifically inhibited by I-RNA, a construct containing the 5'-UTR of Bip mRNA linked to a reporter gene (luciferase) was obtained from P. Sarnow (University of Colorado). The translation of this mRNA in HeLa extracts generated the luciferase protein (Fig. 8C, lane 1) . The addition of yeast I-RNA completely inhibited luciferase synthesis from this RNA construct (Fig. 8C, lane 2) . As expected, capdependent translation from a CAT construct was not at all inhibited under the same conditions (Fig. 8C, lanes 3 and 4) . In fact, CAT translation was significantly stimulated over that of the control as previously observed (10) . These results suggest that yeast I-RNA is capable of inhibiting internal initiation from a cellular mRNA.
To examine the possibility that luciferase translation from the Bip UTR construct was nonspecifically inhibited by I-RNA, a monocistronic luciferase construct which did not contain the Bip IRES sequence was obtained. Translation from this construct is known to occur by a cap-dependent mechanism. Translation from this RNA was inhibited by only 7% in the presence of the inhibitor compared with the control (Fig. 8B, lanes 4 and 3, respectively) . Under similar conditions, translation from the poliovirus IRES containing the P2CAT construct was inhibited by 72% compared with the control (Fig. 8B, lanes 1 and 2) .
Yeast I-RNA inhibits the translation of poliovirus RNA in vivo. Previous studies from our laboratory (10) and the results presented here suggested that yeast I-RNA inhibits virus IRES-dependent translation in vitro. To determine whether I-RNA inhibits the translation of poliovirus RNA in vivo, poliovirus RNA was transfected into HeLa cells singly or together with purified yeast RNA. Proteins were labeled by the addition of [3 S]methionine, and the synthesis of viral proteins was monitored by direct analysis of cell extracts (Fig. 9A) or by immunoprecipitation of viral capsid proteins by anti-capsid antisera (Fig. 9B) . In the absence of added virus RNA and I-RNA, the synthesis of cellular proteins was evident (Fig. 9A,  lane 1) . When virus RNA (1 ,ug) was transfected into cells, the synthesis of distinct viral proteins was observed (Fig. 9A, lane  2) . In addition, the background of host cell proteins diminished considerably because of the shutoff of host cell protein synthesis by poliovirus (Fig. 9A, lane 2) . When I-RNA was cotransfected with virus RNA (1 ,ug) into HeLa cells, no detectable synthesis of viral proteins was observed and host cell protein synthesis was restored (Fig. 9A, lane 3) . The expression of I-RNA alone did not interfere with the synthesis of cellular proteins (Fig. 9A, lane 4) . Figure 9A , lane 5, shows that the carrier tRNA used in transfection experiments had no effect on cellular protein synthesis. The transfection of cells with an increased amount of poliovirus RNA (2 ,ug) (Fig. 9B, lane 3) . Thus, yeast I-RNA efficiently inhibited translation from poliovirus RNA in vivo. Although not shown here, the protection of monolayer cells from the cytolytic effects of poliovirus infection in the presence of yeast I-RNA paralleled the restoration of host cell protein synthesis seen in lanes 3 and 7 of Fig. 9A . Figure 9C represents an experiment similar that shown in Fig. 9A except that two important controls are included. First, the transfection of an unrelated nonspecific RNA similar in size to I-RNA along with poliovirus RNA did not result in the inhibition of viral protein synthesis (compare lanes 2 and 5 in Fig. 9C) . Secondly, the translation-inhibitory effect of I-RNA in cotransfected cells (Fig. 9C, lane 4) (Fig.   2) . Secondly, using a bicistronic construct which contains the poliovirus IRES between two cistrons, we have shown that translation from the second cistron is specifically inhibited by I-RNA, whereas translation from the first cistron is not affected at all by the inhibitor (Fig. 8) . The translation of poliovirus RNA in vivo is inhibited when cells are cotransfected with virus RNA and I-RNA (Fig. 9 ). This inhibition can be reversed by the inclusion of an equimolar amount of antisense I-RNA during cotransfection. Additionally, translation mediated by the 5'-UTR of Bip mRNA, which is known to initiate translation internally, is also inhibited by I-RNA (Fig.   8 ). Finally, I-RNA appears to specifically interact with at least one polypeptide (p52) believed to be involved in the internal initiation of translation (Fig. 4 and 6 (Fig. 2C ). This sequence potentially forms two stem-loop structures, SL-E and SL-F (Fig. 5 ). Dildine (15) . The relationship between the 52-kDa protein that binds to nucleotides 320 to 461 (Fig. 7) and the 48-kDa protein seen by Gebhard and Ehrenfeld remains unclear at present.
Purified yeast I-RNA is able to inhibit virus replication in cells transfected with poliovirus RNA presumably by inhibiting virus translation (Fig. 9) It is worth noting that an antisense RNA with an exact complementary sequence of I-RNA is as efficient in binding p52 as the sense I-RNA molecule (data not shown). This result, taken together with the fact that there is no apparent sequence homology with poliovirus RNA, suggests that the secondary structure of I-RNA may play a crucial role in the inhibition of internal initiation of translation. Indeed, two computer-predicted secondary structures of I-RNA that are thermodynamically relatively stable could be generated (data not shown). These structures partly resemble the p52-binding site on poliovirus mRNA. Thus, it may be the secondary structure rather than the primary sequence of I-RNA that is responsible for its ability to bind p52 or other proteins necessary for the internal initiation of translation.
The normal function of I-RNA in yeast cells remains unknown at present. Altman et al. previously reported that a strain of S. cerevisiae can translate (albeit inefficiently) UTR-CAT gene fusions present as the second gene in bicistronic RNAs (2) . An intriguing possibility is that yeast cells contain genes which initiate translation internally and that I-RNA can be used to regulate the expression of these genes posttranscriptionally. So far, two cellular mRNAs, one encoding the immunoglobulin heavy-chain Bip protein and the other encoding the Drosophila Antennapedia protein, have been shown to be translated by a mechanism involving internal ribosome entry. We have shown here that purified I-RNA inhibits the in vitro translation programmed by Bip 5'-UTR (Fig. 8) . In studies to be published elsewhere, we have shown that the inhibitor specifically inhibits the translation of other picornaviruses, including rhino-, hepatitis A, and Thieler's murine encephalomyelitis viruses. Thus, both a cellular RNA and a number of picornavirus RNAs known to initiate translation internally are inhibited by the same inhibitor. Future studies should utilize yeast I-RNA as a probe to understand in detail the mechanism(s) of the internal initiation of translation in eukaryotes.
